Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Sep. 30, 2022
Current Assets    
Cash and cash equivalents $ 193.9 $ 232.2
Trade receivables, net 326.6 252.9
Receivables from long-term manufacturing contracts, net 270.3 213.3
Inventories, net 591.6 485.6
Prepaid expenses and other current assets 132.9 102.8
Current assets held for sale 238.0 116.1
Total current assets 1,753.3 1,402.9
Property, plant, and equipment, net 285.2 231.9
Operating lease right-of-use assets, net 106.0 87.9
Intangible assets, net 1,095.1 808.0
Goodwill 1,562.7 1,151.1
Other long-term assets 83.6 80.4
Long-term assets held for sale 0.0 105.3
Total Assets 4,885.9 3,867.5
Current Liabilities    
Trade accounts payable 397.3 371.0
Liabilities from long-term manufacturing contracts and advances 392.3 290.3
Current portion of long-term debt 10.0 0.0
Accrued compensation 93.1 97.0
Current liabilities held for sale 130.6 113.8
Other current liabilities 240.6 205.7
Total current liabilities 1,263.9 1,077.8
Long-term debt 1,890.4 1,222.1
Accrued pension and postretirement healthcare 111.6 101.3
Operating lease liabilities 82.3 70.5
Deferred income taxes 291.1 210.2
Other long-term liabilities 53.8 51.8
Long-term liabilities held for sale 0.0 25.8
Total Liabilities 3,693.1 2,759.5
Commitments and contingencies (Note 16)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 69.3 and 68.9 shares outstanding) 0.0 0.0
Additional paid-in capital 706.5 723.8
Retained earnings 842.0 812.0
Treasury stock (6.5 and 6.9 shares, at cost) (277.0) (297.3)
Accumulated other comprehensive loss (108.9) (155.6)
Hillenbrand Shareholders’ Equity 1,162.6 1,082.9
Noncontrolling interests 30.2 25.1
Total Shareholders’ Equity 1,192.8 1,108.0
Total Liabilities and Shareholders’ Equity $ 4,885.9 $ 3,867.5